GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FluoGuide AS (OSTO:FLUO) » Definitions » Common Stock

FluoGuide AS (OSTO:FLUO) Common Stock : kr2.10 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is FluoGuide AS Common Stock?

FluoGuide AS's quarterly common stock increased from Jun. 2024 (kr2.06 Mil) to Sep. 2024 (kr2.07 Mil) and increased from Sep. 2024 (kr2.07 Mil) to Dec. 2024 (kr2.10 Mil).

FluoGuide AS's annual common stock increased from Dec. 2022 (kr1.75 Mil) to Dec. 2023 (kr1.83 Mil) and increased from Dec. 2023 (kr1.83 Mil) to Dec. 2024 (kr2.10 Mil).


FluoGuide AS Common Stock Historical Data

The historical data trend for FluoGuide AS's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FluoGuide AS Common Stock Chart

FluoGuide AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial 1.44 1.56 1.75 1.83 2.10

FluoGuide AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.83 1.85 2.06 2.07 2.10

FluoGuide AS Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


FluoGuide AS Business Description

Traded in Other Exchanges
Address
Titanhus, Titangade 9-13, Copenhagen, DNK, DK-2200
FluoGuide AS is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer fluorescent. Its technology includes uPAR, which is part of a proteolytic system, and FG001, a product injected into the patient's vein prior to surgery.

FluoGuide AS Headlines

No Headlines